Polymorphisms of complement factor genes and age-related macular degeneration in a german population;Komplementfaktor-polymorphismen und altersassoziierte makuladegeneration in einer gruppe deutscher patienten

Klinische Monatsblatter fur Augenheilkunde

Volumn 226, Issue 8, 2009, Pages 654-658

  Baatz, H ^a   Poupel, L ^b   Coudert, M ^c   Sennlaub, F ^d   Combadiere, C ^b  

^a GOETHE UNIVERSITY   (Germany)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

AMD; Genetics; Retina

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; GENOMIC DNA; COMPLEMENT;

AGED; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; RETINA MACULA AGE RELATED DEGENERATION; SALIVA; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; PREVALENCE; RETINA MACULA DEGENERATION; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; COMPLEMENT SYSTEM PROTEINS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MACULAR DEGENERATION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 70350465367     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109318     Document Type: Article

References (36)

1. Assink J JM, Klaver C CW, Houwing-Duistermaat J J. et al. Heterogeneity of the genetic risk in age-related macular disease: a population-based familial risk study. Ophthalmology 2005 112 482-487
2. Balding D J. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006 7 781-791
3. Chen L J., Liu D TL, Tam P OS et al. Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis 2006 12 1536-1542
4. Chowers I, Cohen Y, Goldenberg-Cohen N et al. Association of complement factor H Y 402 H polymorphism with phenotype of neovascular age related macular degeneration in Israel. Mol Vis 2008 14 1829-1834
5. Despriet D DG, Klaver C CW, Witteman J CM et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006 296 301-309
6. Droz I, Mantel I, Ambresin A et al. Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism. Br J Ophthalmol 2008 92 513-517
7. rd, Abel K J. et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005 308 421-424
8. Fisher S A., Rivera A, Fritsche L G. et al. Assessment of the contribution of CFH and chromosome 10q26 AMD susceptibility loci in a Russian population isolate. Br J Ophthalmol 2007 91 576-578
9. Gold B, Merriam J E., Zernant J et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006 38 458-462
10. Gotoh N, Yamada R, Hiratani H et al. No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese. Hum Genet 2006 120 139-143
11. Hageman G S., Anderson D H., Johnson L V. et al. A common haplotype in the complement regulatory gene factor H (HF1 /CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005 102 7227-7232
12. Hageman G S., Luthert P J., Victor Chong N H. et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruchs membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001 20 705-732
13. Haines J L., Hauser M A., Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005 308 419-421
14. Kaur I, Hussain A, Hussain N et al. Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci 2006 47 3729-3735
15. Kim N R., Kang J H., Kwon O W. et al. Association between complement factor H gene polymorphisms and neovascular age-related macular degeneration in Koreans. Invest Ophthalmol Vis Sci 2008 49 2071-2076
16. Klaver C C., Wolfs R C., Assink J J. et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 1998 116 1646-1651
17. Klein B E., Klein R, Lee K E. et al. Risk of incident age-related eye diseases in people with an affected sibling: The Beaver Dam Eye Study. Am J Epidemiol 2001 154 207-211
18. Klein R J., Zeiss C, Chew E Y. et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005 308 385-389
19. Knauer C, Pfeiffer N. Erblindung in Deutschland Heute und 2030. Ophthalmologe 2006 103 735-741
20. Lavergne E, Labreuche J, Daoudi M et al. Adverse associations between CX 3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease. Arterioscler Thromb Vasc Biol 2005 25 847-853
21. Magnusson K P., Duan S, Sigurdsson H et al. CFH Y 402 H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2006 3 e5
22. Maller J, George S, Purcell S et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006 38 1055-1059
23. Richardson A, Islam F, Guymer R et al. Analysis of rare variants in the complement component 2 (C2) and Factor B (BF) genes refine association for age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 2008 Epub ahead of print
24. Scholl H PN, Charbel Issa P, Walier M et al. Systemic complement activation in age-related macular degeneration. PLoS ONE 2008 3 e2593
25. Scholl H PN, Weber B HF, Nothen M M. et al. Y402 H-Polymorphismus in Komplementfaktor H and altersabhängige Makuladegeneration (AMD). Ophthalmologe 2005 102 1029-1035
26. Seddon J M., Ajani U A., Mitchell B D. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997 123 199-206
27. Seddon J M., Cote J, Page W F. et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005 123 321-327
28. Seitsonen S, Lemmela S, Holopainen J et al. Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population. Mol Vis 2006 12 796-801
29. Sepp T, Khan J C., Thurlby D A. et al. Complement factor H variant Y 402 H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 2006 47 536-540
30. Simonelli F, Frisso G, Testa F et al. Polymorphism p.402Y>H in the complement factor H protein is a risk factor for age related macular degeneration in an Italian population. Br J Ophthalmol 2006 90 1142-1145
31. Smith W, Mitchell P. Family history and age-related maculopathy: the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1998 26 203-206
32. Souied E H., Leveziel N, Richard F et al. Y402 H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis 2005 11 1135-1140
33. Spencer K L., Hauser M A., Olson L M. et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 2007 16 1986-1992
34. Spencer K L., Olson L M., Anderson B M. et al. C3 R 102G polymorphism increases risk of age-related macular degeneration. Hum Mol Genet 2008 17 1821-1824
35. Uka J, Tamura H, Kobayashi T et al. No association of complement factor H gene polymorphism and age-related macular degeneration in the Japanese population. Retina 2006 26 985-987
36. Wegscheider B J., Weger M, Renner W et al. Association of complement factor H Y 402 H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 2007 114 738-742